Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Medical Microbiology and Immunology|May 18, 1977
Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challengeY Togo, F E Durr, D A LaurenzanaBioorganic & Medicinal Chemistry Letters|August 30, 2008
Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agentsL Guandalini, C Cellai, A Laurenzana, et al.Leukemia|January 28, 2005
WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potentialA Laurenzana, C Cellai, A M Vannucchi, et al.Current Molecular Medicine|September 1, 2015
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the WayA Laurenzana, G Fibbi, F Margheri, et al.Leukemia|August 11, 2007
Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicityZ Diaz, A Laurenzana, K K Mann, et al.Journal of Experimental & Clinical Cancer Research : CR|June 17, 2017
Type II CRISPR/Cas9 approach in the oncological therapyA Biagioni, A Chillà, E Andreucci, et al.British Journal of Cancer|May 25, 2006
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086C Cellai, A Laurenzana, A M Vannucchi, et al.Journal of Cellular and Molecular Medicine|October 19, 2011
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cellsC Cellai, M Balliu, A Laurenzana, et al.BMC Cancer|March 26, 2017
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progressionS Ciavarella, A Laurenzana, S De Summa, et al.Pageof 1